| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Windtree Therapeutics Inc /de/ (WINT) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. WINT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Fraser Craig | President And CEO | Buy | 2,000 | $0.98 | $1,959.80 | +1.0% | |
| Mar 15, 2022 | Simonson Steven | SVP, Chief Medical Officer | Buy | 5,000 | $1.00 | $4,999.00 | +6.4% | |
| Mar 15, 2022 | Fraser Craig | President And CEO | Buy | 3,000 | $0.98 | $2,940.30 | +1.5% | |
| Dec 30, 2021 | Bioengine Capital Inc. | 10% Owner | Sell | 1,239,088 | $1.60 | $1,982,540.80 | -100% | |
| Dec 30, 2021 | Center Laboratories, Inc. | 10% Owner | Buy | 1,294,260 | $1.84 | $2,382,537.80 | +109.3% | |
| Nov 19, 2021 | Fraser Craig | President And CEO | Buy | 930 | $1.60 | $1,488.00 | +2.5% | |
| Nov 18, 2021 | Fraser Craig | President And CEO | Buy | 930 | $1.61 | $1,497.30 | +2.6% | |
| Oct 22, 2021 | Fraser Craig | President And CEO | Buy | 3,000 | $1.90 | $5,700.00 | +9.0% | |
| Oct 19, 2021 | Huang James | Director | Buy | 50,000 | $1.90 | $95,135.00 | +20.7% | |
| Oct 19, 2021 | Fraser Craig | President And CEO | Buy | 3,000 | $1.91 | $5,730.00 | +9.9% |